Diosmetin alleviates acute lung injury caused by lipopolysaccharide by targeting barrier function
Description
Acute lung injury (ALI) is an acute and devastating disease caused by systemic inflammation e.g. patients infected with bacteria and viruses such as SARS-CoV-2 have an unacceptably high mortality rate. It has been well documented that endothelial
